Jupiter Asset Management
TEVA icon

Jupiter Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Jupiter Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-73,173
Closed -$659K – 656
2020
Q3 		$659K Buy
+73,173
New +$774K 0.01% 493

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Jupiter Asset Management's TEVA Position: Q4 2020 in Review

Jupiter Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2020, closing a stake of 73,173 shares — an estimated $659K sold.

Jupiter Asset Management first reported a position in TEVA in Q3 2020 and held it in 1 quarter. The position peaked at $659K in Q3 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Jupiter Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2020 after selling out during the quarter.
  • Jupiter Asset Management sold 73,173 Teva Pharmaceutical Industries Limited shares in Q4 2020, an estimated $659K.
  • Jupiter Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2020 and held it in 1 quarter.
  • Jupiter Asset Management's Teva Pharmaceutical Industries Limited position peaked at $659K in Q3 2020.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2020.

Based on Jupiter Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.